A University of Otago bioethicist has added his voice to a global plea for a moratorium on heritable genome editing from a group of international scientists and ethicists in the wake of the recent Chinese experiment aiming to produce HIV immune children.
In an article in the latest issue of international scientific journal Nature, Professor Jing-Bao Nie together with another 16 academics from seven countries, call for a global moratorium on all clinical uses of human germline editing to make genetically modified children.
They would like an international governance framework – in which nations voluntarily commit to not approve any use of clinical germline editing unless certain conditions are met – to be created potentially for a five-year period.
Professor Nie says the scientific scandal of the experiment that led to the world’s first genetically modified babies raises many intriguing ethical, social and transcultural / transglobal issues. His main personal concerns include what he describes as the “inadequacy” of the Chinese and international responses to the experiment.
“The Chinese authorities have conducted a preliminary investigation into the scientist’s genetic misadventure and issued a draft new regulation on the related biotechnologies. These are welcome moves. Yet, by putting blame completely on the rogue scientist individually, the institutional failings are overlooked,” Professor Nie explains.
“In the international discourse, partly due to the mentality of dichotomising China and the West, a tendency exists to characterise the scandal as just a Chinese problem. As a result, the global context of the experiment and Chinese science schemes have been far from sufficiently examined.”
The group of 17 scientists and bioethicists say it is imperative that extensive public discussions about the technical, scientific, medical, societal, ethical and moral issues must be considered before germline editing is permitted. A moratorium would provide time to establish broad societal consensus and an international framework.
“For germline editing to even be considered for a clinical application, its safety and efficacy must be sufficient – taking into account the unmet medical need, the risks and potential benefits and the existence of alternative approaches,” the opinion article states.
Although techniques have improved in recent years, germline editing is not yet safe or effective enough to justify any use in the clinic with the risk of failing to make the desired change or of introducing unintended mutations still unacceptably high, the scientists and ethicists say.
“No clinical application of germline editing should be considered unless its long-term biological consequences are sufficiently understood – both for individuals and for the human species.”
The proposed moratorium does not however, apply to germline editing for research uses or in human somatic (non-reproductive) cells to treat diseases.
Professor Nie considers it significant that current presidents of the UK Royal Society, the US National Academy of Medicine and the Director and Associate Director of the US National Institute of Health have expressed their strong support for such a proposed global moratorium in two correspondences published in the same issue of Nature. The editorial in the issue also argues that the right decision can be reached “only through engaging more communities in the debate”.
“The most challenging questions are whether international organisations and different countries will adopt a moratorium and if yes, whether it will be effective at all,” Professor Nie says.
The Latest on: Heritable genome editing
via Google News
The Latest on: Heritable genome editing
- Biden’s Top Science Nominee Advocated ‘Preimplantation Genetic Testing’ to Decide Which Human Embryo to Keepon March 1, 2021 at 11:25 pm
Eric Lander, whom President Joe Biden has nominated to be director of the White House Office of Science and Technology Policy, has opposed actually editing the genes of human embryos while repeatedly ...
- Optimizing the CRISPR/Cas9 system for genome editing in grape by using grape promoterson March 1, 2021 at 10:51 am
3: Targeted mutations generated using the VvU3, VvU6, and UBQ2 promoters. Fig. 4: High-efficiency genome editing in transgenic grapevine plants. Fig. 5: Multiplex editing in grape using multi ...
- WHO launches global registry on human genome editingon February 26, 2021 at 8:32 am
An 18-member WHO expert advisory committee has approved the first phase of a new global registry on human genome editing using the International Clinical Trials Registry Platform (ICTRP), a WHO entity ...
- Wits scientist on global commission that cautions against using gene-edited embryos for pregnancyon February 19, 2021 at 2:14 am
Where does the world stand on designer babies? An international report released in September 2020 advises that heritable genome editing is not yet ready to be tried safely and effectively in humans.
- Implications of hematopoietic stem cells heterogeneity for gene therapieson February 15, 2021 at 11:24 am
Hematopoietic stem cell transplantation (HSCT) is the therapeutic concept to cure the blood/immune system of patients suffering from malignancies, immunodeficiencies, red blood ce ...
- U.S. Panel Supports Use of CRISPR to Genetically Modify Human Embryoson February 10, 2021 at 4:00 pm
The National Academy of Sciences, one of the nation's most influential science advisory groups, announced its support for the use of CRISPR to modify human embryos in a series of heritable germline ...
- CRISPR-Cas guides the future of genetic engineeringon February 2, 2021 at 4:00 pm
The class 2 type II DNA-targeting endonuclease Cas9 (the first Cas effector to be harnessed for genome engineering) has several properties that ensure precise and efficient editing (Box 1A and Fig. 2A ...
- The new frontier of genome engineering with CRISPR-Cas9on February 2, 2021 at 4:00 pm
Doudna and Charpentier review the history of genome editing technologies, including oligonucleotide coupled to genome cleaving agents that rely on endogenous repair and recombination systems to ...
- World 'not yet ready' for embryo gene-editingon September 6, 2020 at 10:21 am
Heritable genome editing includes making alterations to the genetic material of human eggs, sperm, or any cells that lead to their development, including the cells of early embryos, the report ...
- Genome editing not ready to be tried safely and effectively in humans – expertson September 3, 2020 at 7:06 am
Heritable human genome editing (HHGE) is when the DNA of a human embryo, sperm or egg is deliberately altered to influence the characteristics of a future individual. Heritable genome edits can be ...
via Bing News